KALV SG&A Expense Growth
Kalvista Pharmaceuticals Inc · SG&A Expense Growth
KALV SG&A Expense Growth
Latest reported58.01%period ending
KALV FY SG&A Growth (YoY) (0.00% → 58.01%)
Latest values, visible window
High-resolution chart · PNG
KALV sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 58.0078% | |
| 114.2415% | |
| 77.4081% | |
| 15.6886% | |
| 58.9589% | |
| 27.6921% | |
| 19.2477% | |
| 23.2905% | |
| -20.7122% | |
| 321.2966% | |
| 64.9876% | |
| 14.6933% | |
| -0.7082% | |
| 0% |